BioLife Solutions Inc reports results for the quarter ended March 31 - Earnings Summary

• BioLife Solutions Inc BLFS.OQ reported a quarterly adjusted loss of 1 cent​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of nine analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -8 cents to -2 cents per share.

• Revenue fell 24.5% to $23.94 million from a year ago; analysts expected $22.22 million.

• BioLife Solutions Inc's reported EPS for the quarter was a loss of 1 cent​.

• The company reported a quarterly loss of $448 thousand.

• BioLife Solutions Inc shares had fallen by 6.6% this quarter and lost 17.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 11.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for BioLife Solutions Inc is $31.00

This summary was machine generated from LSEG data May 8 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)